Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1987 1
1991 1
1993 1
2002 3
2003 3
2004 1
2005 3
2007 4
2008 6
2009 2
2010 3
2011 4
2012 3
2013 2
2014 7
2015 6
2016 7
2017 7
2018 6
2019 4
2020 3
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.
Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, Zhang CJ, Nichols EM, Malik N, Gregory R, Bantscheff M, Ghidelli-Disse S, Kolev M, Frum T, Spence JR, Sexton JZ, Alysandratos KD, Kotton DN, Pittaluga S, Bibby J, Niyonzima N, Olson MR, Kordasti S, Portilla D, Wobus CE, Laurence A, Lionakis MS, Kemper C, Afzali B, Kazemian M. Yan B, et al. Among authors: olson mr. Sci Immunol. 2021 Apr 7;6(58):eabg0833. doi: 10.1126/sciimmunol.abg0833. Sci Immunol. 2021. PMID: 33827897 Free PMC article.
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, Olson MR, Meng J, Paulus R, Curran WJ Jr, Choy H. Bradley JD, et al. Among authors: olson mr. J Clin Oncol. 2020 Mar 1;38(7):706-714. doi: 10.1200/JCO.19.01162. Epub 2019 Dec 16. J Clin Oncol. 2020. PMID: 31841363 Free PMC article. Clinical Trial.
TH9 immunodeficiency in patients with hyper-IgE syndrome.
Olson MR, Kaplan MH. Olson MR, et al. J Allergy Clin Immunol. 2019 Mar;143(3):935-936. doi: 10.1016/j.jaci.2018.10.044. Epub 2018 Nov 12. J Allergy Clin Immunol. 2019. PMID: 30439405 No abstract available.
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
Imam T, Park S, Kaplan MH, Olson MR. Imam T, et al. Among authors: olson mr. Front Immunol. 2018 Jun 1;9:1212. doi: 10.3389/fimmu.2018.01212. eCollection 2018. Front Immunol. 2018. PMID: 29910812 Free PMC article. Review.
Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
Yan B, Chakravorty S, Mirabelli C, Wang L, Trujillo-Ochoa JL, Chauss D, Kumar D, Lionakis MS, Olson MR, Wobus CE, Afzali B, Kazemian M. Yan B, et al. Among authors: olson mr. bioRxiv. 2021 Feb 17:2021.02.17.431704. doi: 10.1101/2021.02.17.431704. Preprint. bioRxiv. 2021. PMID: 33619483 Free PMC article. Updated.
The development and in vivo function of T helper 9 cells.
Kaplan MH, Hufford MM, Olson MR. Kaplan MH, et al. Among authors: olson mr. Nat Rev Immunol. 2015 May;15(5):295-307. doi: 10.1038/nri3824. Epub 2015 Apr 7. Nat Rev Immunol. 2015. PMID: 25848755 Free PMC article. Review.
Treatment of pediatric hodgkin lymphoma.
Olson MR, Donaldson SS. Olson MR, et al. Curr Treat Options Oncol. 2008 Feb;9(1):81-94. doi: 10.1007/s11864-008-0058-0. Epub 2008 May 7. Curr Treat Options Oncol. 2008. PMID: 18461462 Review.
78 results